US PTAB IP Litigation
8,722 annotated decisions
Page 169 of 364 · 8,722 total
patent · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00317
Verizon and its partners seek Director Review of a PTAB decision that denied institution of an IPR against KT Corp.’s 942 patent. They argue the denial violated due process and misapplied Fintiv factors, urging the Board to institute the review.
patent · Dec 24, 2024
iRhythm, Inc. v.Welch Allyn, Inc. et al.
· IPR2025-00377
iRhythm has requested Director Review of Welch Allyn’s patent 8,214,007 in IPR2025-00377. The patent owner may file a brief response limited to the raised issues within five days, with no new evidence allowed.
patent · Dec 24, 2024
iRhythm, Inc. v.Welch Allyn, Inc. et al.
· IPR2025-00378
The Board acknowledged receipt of Director Review requests for several IPRs, including IPR2025‑00378, and instructed the patent owner to file a limited response within five business days. No new evidence may be submitted.
patent denied · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00317
The Board denied Verizon Wireless and co‑petitioners’ request for Director Review of an institution denial, finding no statutory basis and rejecting new arguments. The institution denial based on a holistic Fintiv analysis therefore stands.
patent denied · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00317
The PTAB denied the petitioners’ request for Director Review of the institution denial in multiple IPRs, including the Verizon Wireless challenge to Pegasus Wireless’s patent. The Board affirmed its original decision not to institute the IPRs.
patent · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00137
Verizon and other carriers have filed a Director Review petition challenging the PTAB’s discretionary denial to institute an IPR on the ’272 patent owned by Korea’s KT Corp. They argue the denial violated due‑process and that institutional review is needed for efficiency and fairness.
patent denied · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00137
The PTAB denied Verizon and co‑petitioners' request for Director Review of the institution decisions in multiple IPRs, including the case covering patent 11,540,272.
patent · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00137
Pegasus Wireless Innovation LLC filed an authorized response opposing Verizon and other carriers’ request for Director Review of the PTAB’s denial to institute an IPR on patent 11,540,272. The response asserts the request lacks statutory basis and introduces impermissible new arguments.
patent · Dec 24, 2024
ITM Isotope Technologies Munich SE v.The Johns Hopkins University et al.
· PGR2025-00012
ITM Isotope Technologies Munich SE petitions the PTAB to invalidate claims of Johns Hopkins' ’201 patent covering low‑molecular‑weight FAP‑α imaging agents, arguing obviousness, lack of enablement, insufficient written description, and indefiniteness.
patent · Dec 24, 2024
Realtek Semiconductor Corp. v.ParkerVision, Inc.
· IPR2025-00325
Realtek has filed an IPR petition challenging ParkerVision’s 9,118,528 patent covering down‑conversion receiver technology, asserting that the claims are obvious over a combination of prior‑art references.
patent · Dec 24, 2024
iRhythm, Inc. v.Welch Allyn, Inc. et al.
· IPR2025-00377
iRhythm has filed an IPR petition challenging 26 claims of Welch Allyn’s wearable heart‑monitor patent, asserting obviousness over Jensen, Kroll and other prior art. The petition argues no discretionary denial factors apply and seeks cancellation of the claims.
patent · Dec 24, 2024
iRhythm, Inc. v.Welch Allyn, Inc. et al.
· IPR2025-00378
iRhythm has filed an IPR petition seeking cancellation of 25 claims of Welch Allyn’s wearable ECG monitor patent, asserting obviousness over multiple prior‑art references.
patent · Dec 24, 2024
Ajinomoto Co., Inc. v.AbTis Co., Ltd.
· IPR2025-00283
Ajinomoto has filed an IPR petition challenging AbTis’s U.S. Patent 11,896,675 covering site‑specific antibody‑drug conjugates. The petitioner alleges lack of written description, improper priority, and that all 13 claims are anticipated or obvious over several pre‑grant publications and conference disclosures. The petition seeks cancellation of every claim.
patent · Dec 24, 2024
Realtek Semiconductor Corp. v.ParkerVision, Inc.
· IPR2025-00324
Realtek has filed an IPR petition challenging claim 14 of ParkerVision’s ‘177 patent, asserting obviousness over Tayloe, a TI multiplexer datasheet, Razavi, and Uzunoglu references. The petition argues that the prior art predates the patent’s critical date and that discretionary denial factors do not apply.
patent · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00317
Verizon and other carriers have filed an IPR petition seeking to invalidate claims of a 5G preemption patent owned by Pegasus Wireless. The petition relies on obviousness over the Kuchibhotla and Chen publications and asks the PTAB to institute the review.
patent · Dec 24, 2024
Cellco Partnership d/b/a Verizon Wireless et al. v.Pegasus Wireless Innovation LLC
· IPR2025-00137
Verizon and co‑petitioners seek to invalidate a 5G resource‑allocation patent owned by Pegasus Wireless, arguing the claims are obvious over prior‑art standards and publications. The petition requests the PTAB to institute the IPR and cancel all 20 challenged claims.
patent instituted · Dec 24, 2024
ITM Isotope Technologies Munich SE v.The Johns Hopkins University et al.
· PGR2025-00012
ITM Isotope Technologies Munich SE challenged The Johns Hopkins University's claims regarding FAP-α targeting moieties based on obviousness and patentability issues (103/112). The Board instituted the PGR, finding that the claims face significant challenges related to enablement and indefiniteness.
patent instituted · Dec 24, 2024
Ajinomoto Co., Inc. v.AbTis Co., Ltd.
· IPR2025-00283
Ajinomoto Co., Inc. successfully convinced the PTAB to institute an IPR against AbTis Co., Ltd.'s patent (11896675) covering Antibody-Drug Conjugates (ADCs). The Board found sufficient evidence for institution on multiple grounds of anticipation and obviousness regarding claim 11.
patent all challenged claims unpatentable · Dec 23, 2024
Samsung Electronics Co., Ltd. et al. v.Molecular Rebar Design, LLC
· IPR2025-00358
Samsung successfully challenged all 16 claims of Molecular Rebar Design’s ’282 patent covering carbon‑nanotube binders for batteries. The Board found the claims obvious over prior art and adopted a construction that “discrete” does not require non‑attachment.
patent · Dec 23, 2024
iRhythm, Inc. v.Welch Allyn, Inc. et al.
· IPR2025-00376
iRhythm has filed a Request for Director Review challenging the USPTO’s discretionary denial of five IPR petitions, arguing the new ‘settled expectations’ rule was applied retroactively and violates precedent. The petitioner contends the rule would burden the PTAB and harm patent quality.
patent all challenged claims upheld · Dec 23, 2024
Samsung Electronics Co., Ltd. et al. v.Molecular Rebar Design, LLC
· IPR2025-00357
Samsung’s IPR challenge to U.S. Patent 8,968,924, covering lithium‑ion battery compositions with discrete carbon nanotubes, was rejected. The Board found no obviousness for any of the five challenged claims, leaving the patent intact.
patent · Dec 23, 2024
iRhythm, Inc. v.Welch Allyn, Inc. et al.
· IPR2025-00374
iRhythm challenges the USPTO’s discretionary denial of its five IPR petitions, arguing the new “settled expectations” rule is retroactive and conflicts with Board precedent. The petition seeks vacatur of the denial and institution of the IPRs.
patent denied · Dec 23, 2024
iRhythm, Inc. v.Welch Allyn, Inc. et al.
· IPR2025-00363
The USPTO Director denied iRhythm’s petitions for review of the USPTO’s discretionary denial to institute several IPRs against Welch Allyn, leaving the original institution denials in place.
patent all challenged claims upheld · Dec 23, 2024
Samsung Electronics Co., Ltd. et al. v.Molecular Rebar Design, LLC
· IPR2025-00356
Samsung’s challenge to Molecular Rebar Design’s lithium‑ion battery patent was rejected. The PTAB held that none of the eight claims were obvious over the cited prior art, leaving the patent fully intact.